Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Biopalette operates a platform designed to provide gene-editing techniques.
Magnolia NeuroSciences discovers and develops drug-like small molecule therapeutics for the prevention of neuronal cell death.
JW Therapeutics is a developer of cell-based therapy technologies created to revolutionize cancer treatment.
Metacrine is a clinical-stage bio pharmaceutical company focused on building an innovative pipeline of best-in-class drugs.
One BioMed is a medical diagnostics company.
BlackThorn Therapeutics is a clinical-stage neurobehavioral health company pioneering the next generation of artificial intelligence.
Genuity Science is a biotechnology company that offers clinco-omics data analysis solutions for researchers.
Rodeo Therapeutics is a developer of small-molecule therapies designed to promote regeneration and repair of multiple tissue types.
Nebula Genomics leverages blockchain technology to eliminate middlemen and empower people to own their personal genomic data.
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
ApoGen Biotechnologies, Inc. is a biotechnology company focused on the development of a new class of therapeutics.
Clinical development and commercialization of innovative aesthetics and medical dermatology products based on scientific breakthroughs
Nohla Therapeutics is a biotechnology company that develops a shelf alternative to bone marrow transplants.
Hua Medicine is a clinical-stage, innovative drug development company in China.
Pioneer Square Labs is a studio that creates and launches technology startups.
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
TRELYS is a biotechnology company based in San Francisco, California.
Genomics Medicine Ireland is an Irish life sciences company conducting a study across Ireland of the human genome.
Juno Therapeutics is a clinical-stage company, develops immunotherapies for the treatment of cancer.
Oncofactor develops cancer therapeutics that disrupt signaling pathways between tumors and the immune system.
ARCH Venture Partners has invested in 236 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
ARCH Venture Partners's top investment sectors include Biotechnology, Health Care, Therapeutics, Pharmaceutical, Medical. The firm invests across 23 different industry categories.
Among tracked funding rounds, Genuity Science received $200.0M in a Series C round. ARCH Venture Partners's total known invested capital is $31.9B.
ARCH Venture Partners's average investment size is $143.1M across its portfolio of 236 companies.
Recent ARCH Venture Partners portfolio additions include Biopalette, Magnolia NeuroSciences, JW Therapeutics. These companies were founded in 2020 or later.